{"id":"W2910326971","doi":"10.1182/blood-2018-99-118577","title":"PD-L1 Blockade with Atezolizumab in Higher-Risk Myelodysplastic Syndrome: An Initial Safety and Efficacy Analysis","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tolerability; Azacitidine; Internal medicine; Oncology; Cohort; Adverse effect; Cancer; Pembrolizumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003624207,0.000277781,0.0006709197,0.0006818292,0.00015573,0.00004632691,0.0001926253,0.0001902983,0.0005443762],"category_scores_gemma":[0.0001799215,0.0002168526,0.00007505903,0.001751865,0.0004268395,0.0001116289,0.0001223527,0.0005651705,0.00008585432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001387619,"about_ca_system_score_gemma":0.0002914466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004047242,"about_ca_topic_score_gemma":0.0003859009,"domain_scores_codex":[0.9976655,0.0001814803,0.0003884597,0.0006373087,0.0005257398,0.0006015557],"domain_scores_gemma":[0.9984553,0.0002347807,0.0001043466,0.0006381498,0.0001512889,0.0004160908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02568457,0.006417482,0.9071001,0.0004129427,0.0123351,0.01495895,0.004004069,0.0002051913,0.005001255,0.0004545206,0.0002879465,0.0231379],"study_design_scores_gemma":[0.02013404,0.003415565,0.9685127,0.000114392,0.003429847,0.0008612637,0.00009195704,0.001184109,0.001411905,0.00002619252,0.0005044366,0.0003135903],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964374,0.0001276429,0.0001279812,0.000363364,0.00004095112,0.0004296341,0.00003926833,0.0000922481,0.002341484],"genre_scores_gemma":[0.9976344,0.0001019374,0.001191263,0.00009129912,0.0003068137,0.00001762466,0.00007422327,0.00004964538,0.00053278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06141263,"threshold_uncertainty_score":0.8842992,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01759514171835927,"score_gpt":0.2900716015480648,"score_spread":0.2724764598297056,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}